Immunoassay Market Research Report - Forecast to 2023

Immunoassay Market Research Report - Forecast to 2023

ID: MRFR/HC/4385-HCRR | October, 2018 | Region: Global | 100 pages | Half-Cooked Research Reports

Immunoassay market research report: By Product and Service (Reagents & Kits, Analyzers, Software, and Services), Type (RIA, CIA, ELISA, FIA, and CLIA), Application (Oncology, Toxicology, Neonatal Screening, Others), End-User – Global forecast till 2023


Market Scenario


An immunoassay is a test based on biochemistry to measure the concentration of an analyte. The analytes are antibodies that are produced due to infection or small molecules. Immunoassays are highly adaptable which are designed to detect the binding of the specific antibody to the target analyte.


It is noted that the increasing prevalence of chronic conditions will push the demand for advanced immunoassay technologies. According to the statistics suggested by the Centers for Disease Control and Prevention, around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States.


Various other factors such as growth in the biotechnology and pharmaceutical sectors, increasing adoption of rental immunoassay analyzers, increasing use of immunoassay in oncology, growing awareness about immunoassay, healthcare insurance coverage for various infectious diseases, unmet medical needs, improving regulatory framework, and increasing government assistance are continuously contributing to the growth of the global immunoassay market.


In March 2013, Bio-Rad Laboratories, Inc launched its Bio-Plex at the Society of Toxicology (SOT) annual meeting in San Antonio, USA. Bio-Rad Laboratories developed this new product in association with Myriad RBM, Inc. for early detection of kidney toxicity and injury.


Despite these drivers, there are some issues associated with the immunoassay market. The stringent FDA regulations, lack of specificity, the complex procedure of testing, and poor healthcare system in low- and middle-income countries may hamper the growth of the market to an extent.


It is estimated that the immunoassay market is expected to grow at a CAGR 8.5% during the forecast period of 2017–2023.


Research Methodology


 immunoassay market


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Pharmaceutical Companies

  • Medical Device Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities


Segmentation


The global immunoassay market is segmented on the basis of product and service, type, and end-user.


On the basis of product and service, the market is classified as reagents and kits, analyzers, and software and services. The reagents and kits segment is classified as Enzyme-Linked Immunosorbent Assay (ELISA) reagents and kits, rapid test reagents and kits, western blot reagents and kits, elispot reagents and kits, RIA reagents and kits, and PCR reagents and kits. The analyzers segment is classified as portable analyzers and benchtop analyzers.


On the basis of type, the market is classified as Radioimmunoassay (RIA), Counting Immunoassay (CIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoroimmunoassay (FIA), and Chemiluminescence immunoassay (CLIA).


On the basis of application, the market is classified as infectious diseases, oncology, autoimmune disorders, toxicology, neonatal screening, cardiology, hematology and blood screening, bone and mineral disorders, and others.


On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, research and academic laboratories, pharmaceutical companies, biotechnology companies, and others.


Regional Analysis


The Americas dominates the immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States. It is also reported that nearly 16.8 million individuals visit physician offices for infectious and parasitic diseases.


Europe holds the second position in the immunoassay market. It is expected that the funding provided by the government and private organizations towards research and development and the rising prevalence of infectious disease are likely to drive the European market.


Owing to a huge patient pool and the increasing demand and development in the healthcare technology, Asia Pacific is the fastest growing immunoassay market. Healthcare expenditure is found to be improving in various regions in Asia Pacific. According to the data suggested by the Australian Institute of Health and Welfare during the year 2015–16, the total health expenditure was USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015. The rising cases of bladder cancer are also propelling the market growth in the Asia Pacific region. According to a 2016 study published in the Journal of Translational Medicine, nearly 12,000 patients are newly diagnosed with bladder cancer, and around 5000 patients die from the disease annually in Japan. The onset of this disease is mostly seen in the more elderly population. A multiplex urinary immunoassay is commonly used for the detection of bladder cancer.


The Middle East and Africa holds the lowest share in the global immunoassay market due to low development, lack of technical knowledge, and poor medical facilities.


Key Players


Some of key the players in the global immunoassay treatment market are Beckman Coulter, Inc., Abbott Laboratories, Radiometer, Alere, Arlington Scientific, Bio-Rad Laboratories, BioMerieux, Inc., DiaSorin, Diamedix, Dynex Technologies, Fujirebio US, Gold Standard Diagnostics, Hycor Biomedical, Inova Diagnostics, Ortho-Clinical Diagnostics, Randox Toxicology, F. Hoffmann-La Roche Ltd., Siemens Healthineers, ThermoFisher Scientific, TOSOH Bioscience, Wako Diagnostics, Shenzhen New Industries Biomedical Engineering Co., Ltd., Sysmex Corporation, and others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Immunoassay Market, by Product & Service

6.1 Introduction

6.2 Reagents & Kits

6.2.1 Market Estimates & Forecast, 2017–2023

6.3 Analyzers

6.3.1 Market Estimates & Forecast, 2017–2023

6.4 Software and Services

6.4.1 Market Estimates & Forecast, 2017–2023

Chapter 7. Global Immunoassay Market, by Type

7.1 Introduction

7.2 Radioimmunoassay (RIA)

7.2.1 Market Estimates & Forecast, 2017–2023

7.3 Counting Immunoassay (CIA)

7.3.1 Market Estimates & Forecast, 2017–2023

7.4 Enzyme-Linked Immunosorbent Assays (ELISA)

7.4.1 Market Estimates & Forecast, 2017–2023

7.5 Fluoroimmunoassay (FIA)

7.5.1 Market Estimates & Forecast, 2017–2023

7.6 Chemiluminescence Immunoassay (CLIA)

7.6.1 Market Estimates & Forecast, 2017–2023

Chapter 8. Global Immunoassay Market, by Application

8.1 Introduction

8.2 Infectious. Diseases

8.2.1 Market Estimates & Forecast, 2017–2023

8.3 Oncology

8.3.1 Market Estimates & Forecast, 2017–2023

8.4 Autoimmune Disorders

8.4.1 Market Estimates & Forecast, 2017–2023

8.5 Toxicology

8.5.1 Market Estimates & Forecast, 2017–2023

8.6 Neonatal Screening

8.6.1 Market Estimates & Forecast, 2017–2023

8.7 Cardiology

8.7.1 Market Estimates & Forecast, 2017–2023

8.8 Hematology & Blood Screening

8.8.1 Market Estimates & Forecast, 2017–2023

8.9 Others

8.9.1 Market Estimates & Forecast, 2017–2023



Chapter 9. Global Immunoassay Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2017–2023

9.3 Diagnostic Laboratories

9.3.1 Market Estimates & Forecast, 2017–2023

9.4 Research & Academic Laboratories

9.4.1 Market Estimates & Forecast, 2017–2023

9.5 Pharmaceutical Companies

9.5.1 Market Estimates & Forecast, 2017–2023

9.6 Biotechnology Companies

9.6.1 Market Estimates & Forecast, 2017–2023

9.7 Others

9.7.1 Market Estimates & Forecast, 2017–2023

Chapter 10. Global Immunoassay Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Beckman Coulter, Inc.

12.1.1 Company Overview

12.1.2 Types Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Abbott

12.2.1 Company Overview

12.2.2 Types Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Radiometer

12.3.1 Company Overview

12.3.2 Types Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Alere

12.4.1 Company Overview

12.4.2 Types/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 BIO-RAD LABORATORIES

12.5.1 Company Overview

12.5.2 Types Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 BIO-RAD LABORATORIES Private Limited

12.6.1 Company Overview

12.6.2 Types Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 SIEMENS HEALTHINEERS

12.7.1 Overview

12.7.2 Types Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of the Immunoassay Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Immunoassay Industry Synopsis, 2017–2023

Table 2 Immunoassay Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Immunoassay Market, by Region, 2017–2023, (USD Million)

Table 4 Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 5 Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 6 Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 7 Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 8 North America Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 9 North America Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 10 North America Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 11 North America Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 12 U.S. Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 13 U.S. Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 14 U.S. Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 15 U.S. Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 16 Canada Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 17 Canada Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 18 Canada Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 19 Canada Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 20 South America Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 21 South America Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 22 South America Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 23 South America Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 24 Europe Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 25 Europe Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 26 Europe Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 27 Europe Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 28 Western Europe Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 29 Western Europe Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 30 Western Europe Immunoassay Market, by Application, 2017–2023, (USD Million)



Table 31 Western Europe Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 32 Eastern Europe Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 33 Eastern Europe Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 34 Eastern Europe Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 35 Eastern Europe Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 36 Asia Pacific Immunoassay Market, by Product & Service, 2017–2023, (USD Million)

Table 37 Asia Pacific Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 38 Asia Pacific Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 39 Asia Pacific Immunoassay Market, by End-User, 2017–2023, (USD Million)

Table 40 The Middle East & Africa Immunoassay Market, by Product & Services, 2017–2023, (USD Million)

Table 41 The Middle East & Africa Immunoassay Market, by Type, 2017–2023, (USD Million)

Table 42 The Middle East & Africa Immunoassay Market, by Application, 2017–2023, (USD Million)

Table 43 The Middle East & Africa Immunoassay Market, by End-User, 2017–2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Immunoassay Market

Figure 3 Segmentation Market Dynamics for the Immunoassay Market

Figure 4 Global Immunoassay Market Share, by Product & Services 2016

Figure 5 Global Immunoassay Market Share, by Type, 2016

Figure 6 Global Immunoassay Market Share, by Application, 2016

Figure 7 Global Immunoassay Market Share, by End-User, 2016

Figure 8 Global Immunoassay Market Share, by Region, 2016

Figure 9 North America Immunoassay Market Share, by Country, 2016

Figure 10 Europe Immunoassay Market Share, by Country, 2016

Figure 11 Asia Pacific Immunoassay Market Share, by Country, 2016

Figure 12 Middle East & Africa Immunoassay Market Share, by Country, 2016

Figure 13 Global Immunoassay Market: Company Share Analysis, 2016 (%)

Figure 14 Beckman Coulter, Inc.: Key Financials

Figure 15 Beckman Coulter, Inc. Segmental Revenue

Figure 16 Beckman Coulter, Inc.: Geographical Revenue

Figure 17 Abbott: Key Financials

Figure 18 Abbott: Segmental Revenue

Figure 19 Abbott: Geographical Revenue

Figure 20 Radiometer: Key Financials

Figure 21 Radiometer: Segmental Revenue

Figure 22 Radiometer: Geographical Revenue

Figure 23 Alere: Key Financials

Figure 24 Alere: Segmental Revenue

Figure 25 Alere: Geographical Revenue

Figure 26 BIO-RAD LABORATORIES: Key Financials

Figure 27 BIO-RAD LABORATORIES: Segmental Revenue

Figure 28 BIO-RAD LABORATORIES Geographical Revenue

Figure 29 BioMerieux, Inc. Private Limited: Key Financials

Figure 30 BioMerieux, Inc. Private Limited: Segmental Revenue

Figure 31 BioMerieux, Inc. Private Limited: Geographical Revenue

Figure 32 SIEMENS HEALTHINEERS: Key Financials

Figure 33 SIEMENS HEALTHINEERS: Segmental Revenue

Figure 34 SIEMENS HEALTHINEERS: Geographical Revenue